Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

E-ISSN： 1538-7836|13|6|1019-1027

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.6, 2015-06, pp. : 1019-1027

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of CALR mutations in patients with splanchnic vein thrombosis

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 3, 2015-02 ,pp. : 459-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of the CALR mutation in the diagnosis of splanchnic vein thrombosis

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 601-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 7, 2012-07 ,pp. : 1297-1302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early versus Delayed Introduction of Oral Vitamin K Antagonists in Combination with Low-Molecular-Weight Heparin in the Treatment of Deep Vein Thrombosis

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 70-77

Karger

Access to resources Recommend Favorite

CALR mutations screening should not be studied in splanchnic vein thrombosis

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 588-589

John Wiley & Sons Inc

Access to resources Recommend Favorite